PuSH - Publikationsserver des Helmholtz Zentrums München

40 Datensätze gefunden.
Zum Exportieren der Ergebnisse bitte einloggen.
Alle Publikationen dieser Seite in den Korb legen
1.
Farnoud, A. ; Orak, S. & Schmid, O.: Numerical models of respiratory drug deposition and pharmacokinetics: Application to liposomal ciclosporin a (L-CSA). J. Aerosol Med. Pulm. Drug Deliv. 32, A9-A9 (2019)
2.
Orak, S. et al.: Towards prediction of the pharmacokinetics of inhaled nanomedicine from physiological cell models: A case study with liposomal ciclosporin A (L-CSA) using the vitrocell cloud system. J. Aerosol Med. Pulm. Drug Deliv. 32, A7-A7 (2019)
4.
Yang, L. et al.: Novel imaging tolls for deciphering pulmonary aerosol deposition with single-cell resolution in non-dissectes murine lungs. J. Aerosol Med. Pulm. Drug Deliv. 32, A12-A12 (2019)
5.
Schmid, O.: In Memoriam: Dr. Winfried Moller. J. Aerosol Med. Pulm. Drug Deliv. 31, 119-119 (2018)
6.
Schmid, O. et al.: Biokinetics of aerosolized liposomal ciclosporin A in human lung cells in vitro using an air-liquid cell interface exposure system. J. Aerosol Med. Pulm. Drug Deliv. 30, 411-424 (2017)
7.
Darquenne, C.* et al.: Bridging the gap between science and clinical efficacy: Physiology, imaging, and modeling of aerosols in the lung. J. Aerosol Med. Pulm. Drug Deliv. 29, 107-126 (2016)
8.
Ferron, G.A. & Karg, E.W.: Model of the hygroscopic particle deposition in the mouse lungs. J. Aerosol Med. Pulm. Drug Deliv. 28, A38 (2015)
9.
Hofmann, W.* ; Winkler-Heil, R.* ; Möller, W. ; Madl, P.* & Schmidt, O.: Modeling particle deposition in the mouse lung and extrapolation to the human lung. J. Aerosol Med. Pulm. Drug Deliv. 28, A43-A43 (2015)
10.
Karg, E.W. ; Ferron, G.A. ; Muelhopt, S.* ; Paur, H.* & Zimmermann, R.*: Is the deposited dose in an air-liquid-interface exposure system comparable to the human lungs? J. Aerosol Med. Pulm. Drug Deliv. 28, A34 (2015)
12.
Möller, W. et al.: In vivo and ex vivo imaging of fluorescent markers in mouse lungs: Assessment of dose and 3D-distribution. J. Aerosol Med. Pulm. Drug Deliv. 28, A38 (2015)
13.
Schittny, J.C.* et al.: High resolution phase contrast imaging of sub-micron particles in unstained lung parenchyma. J. Aerosol Med. Pulm. Drug Deliv. 28, A40-A41 (2015)
14.
Lenz, A.-G. et al.: Validation of the alice-cloud technology for functional efficacy studie with aerosolized drugs delivered to cells at the air-liquid interface. J. Aerosol Med. Pulm. Drug Deliv. 27, A16 (2014)
15.
Löndahl, J.* et al.: Measurement techniques for respiratory tract deposition of airborne nanoparticles: A critical review. J. Aerosol Med. Pulm. Drug Deliv. 27, 229-254 (2014)
16.
Möller, W. et al.: Drug delivery to paranasal sinuses using pulsating aerosols. J. Aerosol Med. Pulm. Drug Deliv. 27, 255-263 (2014)
17.
Ferron, G.A. ; Upadhyay, S. ; Zimmermann, R. & Karg, E.W.: Model of the deposition of aerosol particles in the respiratory tract of the rat. II. Hygroscopic particle deposition. J. Aerosol Med. Pulm. Drug Deliv. 26, 101-119 (2013)
18.
Lenz, A.-G. et al.: Utilizing an efficient air-liquid interface cell exposure system (Alice) for in vitro efficacy testing of aerosolized liquid drugs. J. Aerosol Med. Pulm. Drug Deliv. 26, A16-A17 (2013)
19.
Möller, W. et al.: Drug delivery to paranasal sinuses using pulsating aerosols. J. Aerosol Med. Pulm. Drug Deliv. 26, A11-A11 (2013)
20.
Möller, W. et al.: Upper airway dead space clearance kinetics and efficiency during nasal high flow. J. Aerosol Med. Pulm. Drug Deliv. 26, A39-A40 (2013)